Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.

Thomas Jens EttrichAndreas W BergerLukas PerkhoferSeverin DaumAlexander KönigAndreas DickhutUwe WittelKai WilleMichael GeisslerHana AlgülEike GallmeierJens AtzpodienMarko KornmannRainer MucheNicole PrasnikarAndrea TannapfelAnke Reinacher-SchickWaldemar UhlThomas Seufferlein

Published in: BMC cancer (2018)

ClinicalTrials.gov : NCT02047513, 08/13/2014.

Keyphrases

locally advanced
phase ii study
rectal cancer
early stage
squamous cell carcinoma
radiation therapy
phase iii
study protocol
clinical trial
open label
phase ii
advanced non small cell lung cancer
randomized controlled trial
tyrosine kinase
epidermal growth factor receptor